5-hydroxydecanoate has been researched along with 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwal, K; Dzwonczyk, S; Grover, GJ; Murray, HN; Sargent, CA; Tuttle, JG; Wilde, MW | 1 |
1 other study(ies) available for 5-hydroxydecanoate and 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one
| Article | Year |
|---|---|
Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Coronary Circulation; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Heart; Hydroxy Acids; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Naphthalenes; Phospholipases A; Phospholipases A2; Pyrones; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 1996 |